title: Accessing investigational anticancer agents outside of clinical trials.
authors.affiliation: Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA. montellom@ctep.nci.nih.gov
authors.forename: M J
authors.initials: MJ
authors.lastname: Montello
authors.forename: J J
authors.initials: JJ
authors.lastname: Greenblatt
authors.forename: A
authors.initials: A
authors.lastname: Fallavollita
authors.forename: D
authors.initials: D
authors.lastname: Shoemaker
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006297:Health Services Accessibility; D006801:Humans; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy*; D010593:Pharmaceutical Services; D016879:Salvage Therapy; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational